吸人用盐酸氨溴索溶液雾化吸入治疗新生儿肺炎的临床效果研究
2025-08-09李佳俊胡孝成冷美霞杨远策
Clinical Study onthe Eficacy of Aerosol Inhalation of Ambroxol Hydrochloride Solution for Inhalation in the Treatment of Neonatal Pneumonia/LI Jiajun,HU Xiaocheng,LENG Meixia,YANG Yuance.//Medical Innovation of China,2025,22(18): 058-061
[Abstract]Objective:To explore the clinical efectofaerosol inhalationofAmbroxol Hydrochloride Solution for Inhalation in the treatmentof neonatal pneumonia.Method:Atotalof 8O neonateswith pneumoniaadmited to Jiujiang Maternal and Child Health Hospital from March2O24 to March 2O25 were selected.They were divided nto two groups according to the random number table method, with 4O cases ineach group.The control group was given conventional treatment (anti-infection,anti-virus,warmth preservation,etc.), whilethe experimental group was treated with aerosol inhalation of Ambroxol Hydrochloride Solution for Inhalation onthe basis of the control group. Theclinical eficacyrecoveryindicators,inflammatoryfactors,oxygenationindexandincidenceofadverseeactions betwen the two groups were compared.Result:The total effective rate of treatment in the experimental group was higher thanthat in thecontrol group (Plt;0.05) ).Thedisappearance timeofcyanosissymptoms,thedisappearance time ofronal soundsand theoxygen withdrawaltimeinthe experimental group were allearlier than those in thecontrol group,and the hospital stay was shorter than that in the control group ( P lt;0.05).After the treatment,the levels of procalcitonin (PCT),interleukin-6(IL-6),and Creactive protein (CRP)inthe experimental group wereallower" than those inthe control group,and the oxygenation index was higher than that in the control group,the differences were statistically significant (Plt;0.05) .No obvious adverse reactions were observed in the two groups during the treatment period.Conclusion:Ambroxol Hydrochloride Solution for Inhalation for aerosol inhalationcan effectively promote the recoveryof various indicators of neonates with pneumonia to normal,reduce the inflammatory response, improve the oxygenation index,and has high safety and definite therapeutic effect.
[KeyWords]Neonatal pneumoniaAmbroxol Hydrochloride Solution for Inhalation Aerosol inhalation
First-author'saddress:DepartmentofNeonatology,JiujiangMaternaland ChildHealthHospital, iujiang 332000, China
doi:10.3969/j.issn.1674-4985.2025.18.014
肺炎是新生儿期常见的疾病,由于新生儿防御功能低下,肺组织发育不完善,易发生感染,分泌物不能排出从而导致一系列病理生理改变[-2]。目前,临床治疗新生儿肺炎主要采取常规治疗,如吸氧、抗感染、保暖等措施,但单纯常规治疗效果有限[]。雾化吸入作为一种局部给药方式,能使药物直接作用于呼吸道,在呼吸系统疾病治疗中应用广泛。而吸入用盐酸氨溴索溶液能溶解痰液、助排痰并增强呼吸道纤毛活动[4。基于此,本研究具体分析吸入用盐酸氨溴索溶液雾化吸入治疗新生儿肺炎的临床效果。
1资料与方法
1.1一般资料
选择2024年3月一2025年3月九江市妇幼保健院收治的80例肺炎新生儿为研究对象。纳入标准:均为新生儿肺炎,通过临床症状、影像学和实验室检查确诊;均为出生后 28d 内的新生儿;均伴随一定程度的呼吸急促或呼吸窘迫,肺功能受损或肺炎严重。排除标准:有过敏反应或明显不耐受吸入用盐酸氨溴索溶液或其成分;伴随严重疾病或器官功能不全,如严重心脏病、肾功能衰竭等。按照随机数字表法分为两组,各40例。本研究经九江市妇幼保健院医学伦理委员会批准(伦理批件号:LLSC-2023-118);患儿法定监护人理解研究的性质并同意参与。
1.2 方法
对照组予以常规治疗(抗感染、抗病毒、保暖等),主要予以患儿保暖干预,采用头孢类、阿奇霉素等实现抗感染治疗。在对照组基础上,试验组加用吸入用盐酸氨溴索溶液(HanmiPharm.Co.,Ltd.,国药准字H20190041, 2mL:15mg )治疗,将 2mL 盐酸氨漠索溶液与 1mL 浓度为 0.9% 的氯化钠溶液进行混合,配置成雾化吸人液,每日雾化吸入1或2次,每次吸入时间为 10~15min ,连续给予雾化3\~5d治疗。……
